Posaconazole Tablet, Delayed Release
Product Images NDC 42291-919

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Posaconazole (NDC 42291-919). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

60 (919 60)

60 (919 60)
The packaging label for Posaconazole delayed-release tablets by AvKARE. The label specifies 100 mg strength, with a total of 60 tablets. It includes storage instructions, a warning that posaconazole and Noxafil tablets are not interchangeable, and manufacturer information including the NDC 42291-919-60. The label also features a barcode and a QR code.*
FDA Label Image

Structural Formula (Posaconazole Delayed Release Tablets 1)

Structural Formula (Posaconazole Delayed Release Tablets 1)
Chemical structure of posaconazole, showing its molecular arrangement including multiple aromatic rings, fluorine atoms, and a triazole ring, consistent with the antifungal agent posaconazole.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.